Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years of age (men or women)
- People diagnosed with type 2 diabetes that requires insulin, with a blood sugar control measure (HbA1c) of 6.5% or higher at the screening visit
- People who have been using insulin treatment for at least 6 months before the screening visit
- Non-smokers, or past smokers who have not smoked for at least 12 months
- People considered to be in generally good health, with no known signs of heart, lung, kidney, liver, digestive, or metabolic disease
- People who are able to give their informed consent to participate
- People who are able to follow the study requirements, including dietary rules, eating specific study foods, keeping a food diary, attending study visits, and providing samples
Who may not be able to join:
- People with known or suspected intolerances, allergies, or sensitivities to the study foods
- People with low levels of haemoglobin (a measure of red blood cells) below 9.5 g/dL at the screening visit, which may indicate anaemia
- People with high blood pressure above 160/100 mmHg at the screening visit
- Women who are pregnant or planning to become pregnant during the study period
- People who have had a major injury or surgery within the past 2 months (or longer, depending on the situation, after discussion with the trial investigator)
- People who follow a vegan diet or other highly restrictive diets (such as the Atkins diet), as assessed by the investigator
- People with a history of an eating disorder, such as anorexia nervosa, bulimia nervosa, or binge eating disorder, that was diagnosed by a health professional
- People who have donated blood within the last 3 months
- People whose weight has changed by more than 5 kg (11 lbs) in either direction in the past 2 months
- People who work overnight or non-standard night shifts
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Indika Edirisinghe, Ph.D, Illinois Institute of Technology
Phone: 312-567-5300
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Plasma Glucose Concentration (mg/dL); Change in Plasma Insulin Concentration (µIU/mL); Change in Plasma Glucagon Concentration (pg/mL); Change in Plasma C-Peptide Concentration (ng/mL); Change in Plasma Triglyceride Concentration (mg/dL); Continuous Glucose Monitoring Metrics During Free-Living Conditions; Average Daily Step Count (steps/day); Average Daily Active Minutes (minutes/day); Average Daily Sleep Duration (hours/night); Average Resting Heart Rate (beats/minute)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.